These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 28845908)

  • 1. Eplerenone might affect atrial fibrosis in patients with hypertension.
    Kawasaki M; Yamada T; Okuyama Y; Morita T; Furukawa Y; Tamaki S; Iwasaki Y; Kikuchi A; Sakata Y; Fukunami M
    Pacing Clin Electrophysiol; 2017 Oct; 40(10):1096-1102. PubMed ID: 28845908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eplerenone Reduces Atrial Fibrillation Burden Without Preventing Atrial Electrical Remodeling.
    Takemoto Y; Ramirez RJ; Kaur K; Salvador-Montañés O; Ponce-Balbuena D; Ramos-Mondragón R; Ennis SR; Guerrero-Serna G; Berenfeld O; Jalife J
    J Am Coll Cardiol; 2017 Dec; 70(23):2893-2905. PubMed ID: 29216985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mineralocorticoid receptor on atrial structural remodeling and inducibility of atrial fibrillation in hypertensive rats.
    Kimura S; Ito M; Tomita M; Hoyano M; Obata H; Ding L; Chinushi M; Hanawa H; Kodama M; Aizawa Y
    Hypertens Res; 2011 May; 34(5):584-91. PubMed ID: 21248754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced dispersion of atrial refractoriness as an electrophysiological substrate for vulnerability to atrial fibrillation in patients with paroxysmal atrial fibrillation.
    Oliveira MM; da Silva N; Timóteo AT; Feliciano J; de Sousa L; Santos S; Marques F; Ferreira R
    Rev Port Cardiol; 2007; 26(7-8):691-702. PubMed ID: 17939579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of eplerenone on P-wave signal-averaged electrocardiogram in hypertensive patients with coronary artery disease.
    Kurisu S; Watanabe N; Ikenaga H; Shimonaga T; Higaki T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Kihara Y
    Int J Cardiol; 2014; 172(1):e180-1. PubMed ID: 24439863
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation.
    Ito Y; Yamasaki H; Naruse Y; Yoshida K; Kaneshiro T; Murakoshi N; Igarashi M; Kuroki K; Machino T; Xu D; Kunugita F; Sekiguchi Y; Sato A; Tada H; Aonuma K
    Am J Cardiol; 2013 Apr; 111(7):1012-8. PubMed ID: 23340033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eplerenone Prevents Atrial Fibrosis via the TGF-β Signaling Pathway.
    Du L; Qin M; Yi Y; Chen X; Jiang W; Zhou L; Zhang D; Xu K; Yang Y; Li C; Liu Y; Liu X; Duan SZ
    Cardiology; 2017; 138(1):55-62. PubMed ID: 28571007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic potential of aldosterone antagonists in atrial fibrillation.
    Dąbrowski R; Szwed H
    Cardiol J; 2012; 19(3):223-9. PubMed ID: 22641540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension.
    White WB; Duprez D; St Hillaire R; Krause S; Roniker B; Kuse-Hamilton J; Weber MA
    Hypertension; 2003 May; 41(5):1021-6. PubMed ID: 12682082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of selective mineralocorticoid receptor antagonism on atrial ion currents and early ionic tachycardia-induced electrical remodelling in rabbits.
    Laszlo R; Bentz K; Konior A; Eick C; Schreiner B; Kettering K; Schreieck J
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Oct; 382(4):347-56. PubMed ID: 20799026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T; Fukuda M; Kataoka K; Nako H; Tokutomi Y; Dong YF; Yamamoto E; Yasuda O; Ogawa H; Kim-Mitsuyama S
    Hypertens Res; 2011 Jul; 34(7):817-24. PubMed ID: 21471977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and the distress they cause: comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension.
    Hollenberg NK; Williams GH; Anderson R; Akhras KS; Bittman RM; Krause SL
    Arch Intern Med; 2003 Jul; 163(13):1543-8. PubMed ID: 12860576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation.
    Lendeckel U; Dobrev D; Goette A
    Br J Pharmacol; 2010 Apr; 159(8):1581-3. PubMed ID: 20388187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor antagonists and atrial fibrillation: a meta-analysis.
    Liu T; Korantzopoulos P; Shao Q; Zhang Z; Letsas KP; Li G
    Europace; 2016 May; 18(5):672-8. PubMed ID: 26705563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducibility of atrial fibrillation during electrophysiologic evaluation is associated with increased dispersion of atrial refractoriness.
    Oliveira M; da Silva MN; Timoteo AT; Feliciano J; Sousa L; Santos S; Silva-Carvalho L; Ferreira R
    Int J Cardiol; 2009 Aug; 136(2):130-5. PubMed ID: 18676037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension.
    Pelliccia F; Rosano G; Patti G; Volterrani M; Greco C; Gaudio C
    Int J Cardiol; 2015 Dec; 200():8-11. PubMed ID: 25466561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure.
    Moore TD; Nawarskas JJ; Anderson JR
    Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
    Fogari R; Derosa G; Ferrari I; Corradi L; Zoppi A; Lazzari P; Santoro T; Preti P; Mugellini A
    Am J Hypertens; 2008 Sep; 21(9):1034-9. PubMed ID: 18566593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B; Reichek N; Willenbrock R; Zannad F; Phillips RA; Roniker B; Kleiman J; Krause S; Burns D; Williams GH
    Circulation; 2003 Oct; 108(15):1831-8. PubMed ID: 14517164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.